Experimental stem cell therapy offers hope for devastating brain disease
NCT ID NCT07238062
Summary
This expanded access program is testing whether stem cell injections can help control multiple system atrophy (MSA), a rare and progressive brain disorder. Up to 7 adults with confirmed MSA will receive monthly IV infusions and spinal injections of donor stem cells over 44 weeks. The main goals are to see if the treatment is safe and if it can slow or improve symptoms of this currently incurable disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Biosciences Research Foundation
Sugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.